AVTX
Avalo Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$18.45-4.75%
Price as of Jul 20, 2026
AVTX ownership
Avalo Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
24
Net (3m)
-$5.6M
Insider trades by month Buys Sells
Nov
Mar
Apr
May
Jun
Jul
Context3-month price +23.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Philip Ron Mdirector | Grant | 69 | $18.48 |
| Jul 2, 2026 | Doyle Mittieofficer: Chief Medical Officer | Option | 2,875 | $12.65 |
| Jul 2, 2026 | Lind Kevin Robertdirector | Grant | 1,105 | $18.48 |
| Jul 2, 2026 | Doyle Mittieofficer: Chief Medical Officer | Sell | 4,654 | $20.00 |
| Jul 2, 2026 | Jain Ritadirector | Grant | 1,080 | $18.48 |
| Jul 2, 2026 | Doyle Mittieofficer: Chief Medical Officer | Option | 1,779 | $8.04 |
| Jun 25, 2026 | Doyle Mittieofficer: Chief Medical Officer | Sell | 1,450 | $18.00 |
| Jun 25, 2026 | Philip Ron Mdirector | Grant | 40,200 | $17.83 |
| Jun 25, 2026 | Doyle Mittieofficer: Chief Medical Officer | Option | 1,450 | $8.04 |
| Jun 12, 2026 | Sullivan Christopher Ryanofficer: Chief Financial Officer | Tax | 138 | $13.10 |
| Jun 12, 2026 | Doyle Mittieofficer: Chief Medical Officer | Tax | 1,084 | $13.10 |
| Jun 12, 2026 | Riley Jenniferofficer: Chief Strategy Officer | Tax | 588 | $13.10 |
| Jun 12, 2026 | VARKI PAULofficer: Chief Legal Officer | Tax | 1,081 | $13.10 |
| Jun 4, 2026 | Lind Kevin Robertdirector | Grant | 20,100 | $13.96 |
| Jun 4, 2026 | Truex Samanthadirector | Grant | 20,100 | $13.96 |
| Jun 4, 2026 | KANTOFF AARONdirector | Grant | 20,100 | $13.96 |
| Jun 4, 2026 | Heffernan Michael Thomasdirector | Grant | 29,500 | $13.96 |
| Jun 4, 2026 | Jain Ritadirector | Grant | 20,100 | $13.96 |
| Jun 4, 2026 | KAPLAN GILLAdirector | Grant | 20,100 | $13.96 |
| Jun 1, 2026 | Doyle Mittieofficer: Chief Medical Officer | Option | 679 | $8.04 |
| Jun 1, 2026 | Doyle Mittieofficer: Chief Medical Officer | Sell | 679 | $16.00 |
| May 26, 2026 | VARKI PAULofficer: Chief Legal Officer | Grant | 24,300 | — |
| May 26, 2026 | Riley Jenniferofficer: Chief Strategy Officer | Grant | 34,200 | — |
| May 26, 2026 | Sullivan Christopher Ryanofficer: Chief Financial Officer | Grant | 39,900 | — |
| May 26, 2026 | Doyle Mittieofficer: Chief Medical Officer | Grant | 43,500 | — |
| May 26, 2026 | NEIL GARRY ARTHURdirector, officer: Chief Executive Officer | Grant | 100,200 | — |
| May 19, 2026 | Doyle Mittieofficer: Chief Medical Officer | Sell | 3,000 | $18.76 |
| May 19, 2026 | Doyle Mittieofficer: Chief Medical Officer | Option | 3,000 | $12.65 |
| May 11, 2026 | Sullivan Christopher Ryanofficer: Chief Financial Officer | Option | 18,606 | $9.88 |
| May 11, 2026 | Sullivan Christopher Ryanofficer: Chief Financial Officer | Sell | 18,606 | $24.12 |
Source: AVTX SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their AVTX positions over the last 6 months (SEC Form 13F).
Increased
61
New positions
70
Reduced
32
Sold out
35
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 2.9M | May 15, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | New Position | 2.2M | May 15, 2026 |
| CALIGAN PARTNERS LP | Increased | 1.6M | May 15, 2026 |
| BVF INC/IL | Increased | 1.6M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | New Position | 1.4M | May 15, 2026 |
| BVF INC/IL | Increased | 1.4M | Feb 17, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 1.3M | May 14, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | New Position | 1.3M | May 15, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 1.2M | Feb 13, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 1.2M | May 15, 2026 |
| ORBIMED ADVISORS LLC | Reduced | 1.2M | Feb 17, 2026 |
| UBS GROUP AG | Increased | 1.1M | May 5, 2026 |
| CAPTION MANAGEMENT, LLC | Increased | 1.1M | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 1.1M | Feb 13, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 916K | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.